Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
464 studies found for:    COATS DISEASE
Show Display Options
Rank Status Study
1 Completed Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Condition: Coat's Disease
Intervention: Drug: anecortave acetate
2 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
3 Completed Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
Condition: Coronary Artery Disease
Intervention: Drug: Paxil-CR
4 Completed Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis
Condition: Parkinson Disease
Intervention: Device: Optical coherence tomography
5 Unknown  First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)
Conditions: Peripheral Artery Disease;   Femoropopliteal Artery Disease
Interventions: Drug: Local drug delivery via microcrystalline paclitaxel balloon coating (PAK,Balton, Poland);   Device: Plain balloon angioplasty, uncoated balloon (Neptun, Balton, Poland)
6 Unknown  Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?
Condition: Alzheimer's Disease
Intervention:
7 Active, not recruiting Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial
Condition: Peripheral Vascular Disease
Intervention: Device: Paclitaxel Coated Chocolate Balloon Angioplasty
8 Active, not recruiting
Has Results
Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease
Condition: Peripheral Arterial Disease (PAD)
Interventions: Device: Drug-Coated Balloon (DCB);   Device: PTA Balloon: Balloon Angioplasty
9 Active, not recruiting Treatment of Coronary Artery Disease (CAD) With Bare Metal Stent (BMS) Followed by Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Eluting Stent
Condition: Coronary Artery Disease
Interventions: Device: Coroflex Blue (BMS) followed by SeQuent Please (DEB);   Device: Coroflex Please (DES)
10 Unknown  Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease
Condition: Coronary Artery Disease
Intervention: Device: Bx Sonic & Cypher stent from Cordis
11 Enrolling by invitation Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
Condition: Stable Coronary Artery Disease
Intervention: Drug: Atorvastatin
12 Recruiting Comparison of Paclitaxel-Coated Balloons Against Everolimus-Eluting Bioresorbable Scaffolds for Elective PCI Using OCT
Condition: Coronary Artery Disease
Interventions: Device: OCT-guided BRS implantation;   Device: FFR-guided DCB-only PCI
13 Completed Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
Conditions: Peripheral Arterial Disease,;   Claudication
Interventions: Device: Cotavance Drug-Eluting Balloon;   Device: TurboHawk/SilverHawk Device followed by a Cotavance Drug-Eluting Balloon;   Device: TurboHawk/SilverHawk Device followed by a Cotavance Drug-Eluting Balloon (N=25)
14 Completed Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries
Condition: Peripheral Arterial Disease
Intervention: Device: paclitaxel coated balloon catheter (device with drug)
15 Completed CVI Drug Coated Balloon First In Human Trial
Condition: Peripheral Arterial Disease
Intervention: Device: Percutaneous Transluminal Angioplasty
16 Recruiting DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions
Condition: Peripheral Vascular Disease
Interventions: Device: Medtronic HawkOne® or TurboHawk™;   Device: Medtronic IN.PACT® Admiral® DCB;   Device: Medtronic Spider™ Distal Protection Device (DPD);   Device: Volcano Visions® PV .014" IVUS catheter;   Device: Nitinol Stent Placement
17 Recruiting First-in-man Study of Titanium-Nitride Coated Woven-nitinol Peripheral Arterial Stent
Condition: Peripheral Arterial Disease
Intervention: Device: GoldenFlow Stent
18 Recruiting Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis
Condition: Peripheral Arterial Disease
Interventions: Device: Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the Superficial Femoral and Popliteal Arteries;   Device: Transluminal Angioplasty with and non-coated (CE-marked) plain old angioplasty balloon (POBA) catheter
19 Completed Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
Condition: Peripheral Artery Disease
Intervention: Procedure: Percutaneous transluminal angioplasty (PTA)
20 Completed A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent
Condition: Coronary Artery Disease
Intervention: Device: NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.